Abstract
Background and aims: In Alzheimer’s disease (AD) olfactory deficits are common and depression is a difficult differential diagnosis. We therefore investigated the usefulness of an odor identification test to differentiate both conditions. Methods: Twenty patients with probable Alzheimer’s disease (AD), twenty elderly patients with a depressive disorder, and thirty healthy elderly subjects performed a German odor identification test. Results: AD patients had significantly lower odor identification scores, compared with both depressive patients and control subjects (F=121.96, df=2, 67, p<0.001). With a cut-off score of 10/11, the sensitivity of the identification test to differentiate AD patients from depressive patients was 100%, and specificity was 95%. Conclusions: The odor identification test used in this study is able to reveal olfactory deficits in AD. It also seems to be a useful instrument to differentiate AD from depression.
References
Thompson MD, Knee K, Golden CJ. Olfaction in persons with Alzheimer’s disease. Neuropsychology Review 1998; 8: 11–23.
Kovács T, Cairns NJ, Lantos PL. Olfactory centres in Alzheimer’s disease. Neuroreport 2001; 12: 285–8.
Attems J, Lintner F, Jellinger KA. Olfactory involvement in aging and Alzheimer’s disease: an autopsy study. J Alzheimers Dis 2005; 7: 149–57.
Christen-Zaech S, Kraftsik R, Pillevuit O, et al. Early olfactory involvement in Alzheimer’s disease. Can J Neurol Sci 2003; 30: 20–5.
Tsuboi Y, Wszolek ZK, Graff-Radford NR, Cookson N, Dickson DW. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein ε4. Neuropathol Appl Neurobiol 2003; 29: 503–10.
Kovács T. Mechanisms of olfactory dysfunction in aging and neurodegenerative disorders. Ageing Research Reviews 2004; 3: 215–32.
Murphy C. Olfactory functional testing: sensitivity and specificity for Alzheimer’s disease. Drug Dev Res 2002; 56: 123–31.
Suzuki Y, Yamamoto S, Umegaki H, et al. Smell identification test as an indicator for cognitive impairment in Alzheimer’s disease. Int J Geriatr Psychiatry 2004; 19: 727–33.
Eibenstein A, Fioretti AB, Simaskou MN, et al. Olfactory screening test in mild cognitive impairment. Neurol Sci 2005; 26: 156–60.
Purandare N, Burns A, Craig S, Faragher B, Scott K. Depressive symptoms in patients with Alzheimer’ disease. Int J Geriatr Psychiatry 2001; 16: 960–4.
Reischies FM, Neu P. Comorbidity of mild cognitive disorder and depression — a neuropsychological analysis. Eur Arch Psychiatry Clin Neurosci 2000; 250: 186–93.
Duff K, McCaffrey RJ, Solomon GS. The Pocket Smell Test: successfully discriminating probable Alzheimer’s dementia from vascular dementia and major depression. J Neuropsychiatry Clin Neurosci 2002; 14: 197–201.
McCaffrey RJ, Duff K, Solomon GS. Olfactory dysfunction discriminates probable Alzheimer’s dementia from major depression. J Neuropsychiatry Clin Neurosci 2000; 12: 29–33.
Solomon GS, Petrie WM, Hart JR, Brackin HB. Olfactory dysfunction discriminates Alzheimer’s dementia from major depression. J Neuropsychiatry Clin Neurosci 1998; 10: 64–7.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer’s disease. Neurology 1984; 34: 939–44.
World Health Organisation (WHO). Tenth revision of the international classification of diseases (ICD-10), chapter V (F), 1993.
Ihl R, Weyer G. Alzheimer’s Disease Assessment Scale (ADAS), German version. Weinheim: Beltz, 1993.
Ihl R, Frölich L. Die Reisberg-Skalen, German version. Weinheim: Beltz, 1991.
Hamilton M. Hamilton Depression Scale. A rating scale for depression. J Neurol Neurosurg Psychiat 1960; 23: 56–62.
Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G. „Sniffin ‘sticks”: olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 1997; 22: 39–52.
Peters JM, Hummel T, Kratzsch T, Lötsch J, Skarke C, Frölich L. Olfactory function in mild cognitive impairment and Alzheimer’s disease: an investigation using psychophysical and electrophysiological techniques. Am J Psychiatry 2003; 160: 1995–2002.
Tangalos EG, Smith GE, Ivnik RJ, et al. The Mini Mental State Examination in general medical practice: clinical utility and acceptance. Mayo Clin Proc 1996; 71: 829–37.
Räihä I, Isoaho R, Ojanlatva A, Viramo P, Sulkava R, Kivelä SL. Poor performance in the Mini Mental State Examination due to causes other than dementia. Scand J Prim Health Care 2001; 19: 34–8.
Serby M, Larson P, Kalkstein D. The nature and course of olfactory deficits in Alzheimer’s disease. Am J Psychiatry 1991; 148: 357–60.
Morgan CD, Nordin S, Murphy C. Odor identification as an early marker for Alzheimer’s disease: impact of lexical functioning and detection sensitivity. J Clin Exp Psychol 1995; 17: 793–803.
Wszolek ZK, Markopoulou K. Olfactory dysfunction in Parkinson’s disease. Clinical Neuroscience 1998; 5: 94–101.
Moberg PJ, Agrin R, Gur RE, Gur RC, Turetsky BI, Doty RL. Olfactory dysfunction in schizophrenia: a qualitative and quantitative review. Neuropsychopharmacology 1999; 21: 325–40.
Martzke JS, Kopala LC, Good KP. Olfactory dysfunction in neuropsychiatric disorders: review and methodological considerations. Biol Psychiatry 1997; 42: 721–32.
Larsson M. Semantic factors in episodic recognition of common odors in early and late adulthood: a review. Chem Senses 1997; 22: 623–33.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pentzek, M., Grass-Kapanke, B. & Ihl, R. Odor identification in Alzheimer’s disease and depression. Aging Clin Exp Res 19, 255–258 (2007). https://doi.org/10.1007/BF03324698
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03324698